Q4 2022 13F Holders as of 31 Dec 2022
-
Type / Class
-
Equity / Class A Stock
-
Shares outstanding
-
115,244,363
-
Total 13F shares
-
75,411,729
-
Share change
-
+1,042,505
-
Total reported value
-
$5,599,365,744
-
Put/Call ratio
-
8.7%
-
Price per share
-
$74.27
-
Number of holders
-
376
-
Value change
-
+$85,497,442
-
Number of buys
-
188
-
Number of sells
-
152
Institutional Holders of GLOBUS MEDICAL INC - Class A Stock (GMED) as of Q4 2022
As of 31 Dec 2022,
GLOBUS MEDICAL INC - Class A Stock (GMED) was held by
376 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
75,411,729 shares.
The largest 10 holders included
BlackRock Inc., VANGUARD GROUP INC, KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC, JANUS HENDERSON GROUP PLC, WELLINGTON MANAGEMENT GROUP LLP, WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC, STATE STREET CORP, Capital Research Global Investors, Champlain Investment Partners, LLC, and Invesco Ltd..
This page lists
381
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.